Overview
What is Pancreatic Cancer Action Network Inc?
Pancreatic Cancer Action Network Inc, located in Manhattan Beach, California, is a dedicated nonprofit organization focused on revolutionizing the approach to detecting and treating pancreatic cancer through groundbreaking research initiatives. With a record investment of $25 million in research grants during fiscal year 2022, the organization has supported significant research projects at numerous institutions and launched initiatives like Precision Promise adaptive clinical trial, Early Detection Initiative, Know Your Tumor Precision Medicine Service, and Patient Registry. Since its inception in 2003, Pancreatic Cancer Action Network has awarded 234 research grants to 213 scientists at 79 institutions, with a cumulative research investment surpassing $174 million. The mission of this organization is multifaceted, encompassing the advancement of scientific research, building communities, sharing knowledge, and advocating on behalf of patients. Their commitment is to transform the lives of everyone affected by pancreatic cancer.
Official website here: www.pancan.org
Is Pancreatic Cancer Action Network Inc legitimate?
Pancreatic Cancer Action Network Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Pancreatic Cancer Action Network Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $1,727,147
Professional Fundraising Fees: $0
Other Salaries and Wages: $17,244,287
For more financial information, click here
Official website here: www.pancan.org
What is the mission statement of Pancreatic Cancer Action Network Inc?
The Pancreatic Cancer Action Network Inc is dedicated to making a substantial impact on the lives of those affected by pancreatic cancer. Their mission encompasses advancing scientific research, building community, sharing knowledge, and advocating for patients. Through their research initiatives, they fund groundbreaking projects aimed at early detection and new treatments for pancreatic cancer. In fiscal year 2022, they allocated a record $25 million to research grants and large-scale clinical projects nationwide. Since 2003, this organization has awarded 234 research grants to 213 scientists at 79 institutions, totaling over $174 million in cumulative research investment.
Official website here: www.pancan.org
Who is the CEO of Pancreatic Cancer Action Network Inc?
Julie Fleshman is the President & Ceo/Director of Pancreatic Cancer Action Network Inc. The CEO's salary of Pancreatic Cancer Action Network Inc is $678,051 and their total compensation is $715,888.
Official website here: www.pancan.org
What is the revenue of Pancreatic Cancer Action Network Inc?
Pancreatic Cancer Action Network Inc's revenue in 2022 was $52,930,843.
Official website here: www.pancan.org
Who are the executives of Pancreatic Cancer Action Network Inc and what are their salaries?
The average compensation at Pancreatic Cancer Action Network Inc during 2022 was $99,327. There are 191 employees and 2,400 volunteers at Pancreatic Cancer Action Network Inc.
Here are 25 key members and their salaries (Pancreatic Cancer Action Network Inc's CEO's salary is $678,051 and their total compensation is $715,888):
- Julie Fleshman (President & Ceo/Director)
- Sudheer Doss (Chief Business Officer)
- Anne-Marie Duliege (Chief Medical Officer Thru 3/2022)
- Lynn Matrisian (Chief Science Officer)
- Lori Stevens (Chief Development Officer)
- Thomas Croal (Cfo Thru 6/2021)
- Edwina Mossett (Chief People Officer)
- Jodi Lipe (Chief Marketing And Communications Officer)
- Richard Leonard (National Director, Leadership Giving)
- Hilarie Koplow-Mc Adams (Chairman) [Trustee/Director]
- Karen Young Cpa (Vice Chairman) [Trustee/Director]
- Marco Argenti (Board Member As Of 7/2021) [Trustee/Director]
- Peter Cashion (Board Member) [Trustee/Director]
- Dennis Cronin (Board Member) [Trustee/Director]
- Scott A Griswold Cpa (Board Member Thru 6/2021) [Trustee/Director]
- Barbara J Kenner Phd (Board Member) [Trustee/Director]
- Michael Ag Korengold (Board Member) [Trustee/Director]
- Jason Kuhn (Board Member) [Trustee/Director]
- Lisa Kulok (Board Member) [Trustee/Director]
- Terrence Meck (Board Member Thru 6/2021) [Trustee/Director]
- Craig A Rogerson (Board Member) [Trustee/Director]
- Nancy Stagliano Phd (Board Member) [Trustee/Director]
- Karyn A Temple (Board Member As Of 7/2021) [Trustee/Director]
- Rod Williams Mba (Board Member) [Trustee/Director]
- Anat Kendal (Cfo As Of 1/2022)
Official website here: www.pancan.org
Where can I find the form 990 for Pancreatic Cancer Action Network Inc?
The Pancreatic Cancer Action Network Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.pancan.org
Learn more at the official website: www.pancan.org
Mission Statement of Pancreatic Cancer Action Network Inc
Pancreatic Cancer Action Network Inc, also known as PANCAN, is a dedicated organization with a bold mission to improve the lives of everyone affected by pancreatic cancer. This mission encompasses several key areas: advancing scientific research, building community, sharing knowledge, and advocating for patients.
In the realm of research, PANCAN funds groundbreaking initiatives to transform the way pancreatic cancer is detected and treated. They provide grants to individual investigators and large-scale clinical projects, all focused on developing new treatments and early detection methods for pancreatic cancer. PANCAN's research investment has reached a significant milestone of over $174 million, making a substantial impact on the diagnosis, treatment, and care of current and future patients. With a record investment of $25 million in fiscal year 2022, PANCAN supports research projects at institutions across the country and contributes to initiatives like the Precision Promise Adaptive Clinical Trial, Early Detection Initiative, Know Your Tumor Precision Medicine Service, and Patient Registry.
Since its inception in 2003, Pancreatic Cancer Action Network Inc has awarded 234 research grants to 213 scientists at 79 institutions. By investing in cutting-edge research, PANCAN is relentlessly pursuing a future where pancreatic cancer can be detected and treated more effectively, ultimately improving the lives of those affected by this disease.
Impact
This information is meant to be a general summary of Pancreatic Cancer Action Network Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Pancreatic Cancer Action Network Inc is making a significant impact in the fight against pancreatic cancer. Through its focus on advancing research, supporting patients, and creating hope for those affected by this disease, the organization is driving progress in the field. Pancreatic Cancer Action Network Inc has invested a record $25 million in research in fiscal year 2022 alone, funding groundbreaking initiatives aimed at transforming the way pancreatic cancer is detected and treated.
By funding research grants to individual investigators and large-scale, multi-institutional clinical projects, Pancreatic Cancer Action Network Inc is at the forefront of advancing new treatments and early detection methods for pancreatic cancer. The organization has awarded 234 research grants to 213 scientists at 79 institutions since 2003, with a cumulative research investment of over $174 million. This significant investment is making a tangible impact on the diagnosis, treatment, and care of both current and future pancreatic cancer patients.
Through initiatives such as the Precision Promise adaptive clinical trial, early detection initiative, Know Your Tumor precision medicine service, and patient registry, Pancreatic Cancer Action Network Inc is actively working to improve outcomes and provide support to those affected by pancreatic cancer. By taking bold action to improve the lives of everyone impacted by this disease, the organization is playing a crucial role in advancing scientific research, building community, sharing knowledge, and advocating for patients.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PRECISION PROMISE PASS-THROUGH &
Revenue
$7,603,876
PRECISION PROMISE PROGRAM FEE
Revenue
$2,053,157
Organization Details
Founding Year
1999
Phone
(310) 725-0025
Principal Officer
Julie Fleshman
Main Address
1500 ROSECRANS AVENUE 200, MANHATTAN BEACH, CA, 90266
Website
www.pancan.org
NTEE Category
Code: G30 - Disease
If you are a representative of Pancreatic Cancer Action Network Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.